Pathogenesis of cholesterol and pigment gallstones: An update

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 4, 2011, Pages 281-287

  Van Erpecum, Karel Johannes ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILE SALT; FARNESOID X RECEPTOR; GLUCURONOSYLTRANSFERASE 1A1; LIVER X RECEPTOR; PHOSPHOLIPID; STEROL;

AQUEOUS SOLUTION; CHOLESTEROL STONE; GALLSTONE FORMATION; GENETIC POLYMORPHISM; HUMAN; PATHOGENESIS; RARE DISEASE; SHORT SURVEY;

BILE; BILE ACIDS AND SALTS; BILIRUBIN; CHOLESTEROL; GALLSTONES; HUMANS; LIPID METABOLISM;

EID: 79955043126     PISSN: 22107401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.01.009     Document Type: Short Survey

References (56)

1. van Erpecum K.J. Biliary lipids, water and cholesterol gallstones. Biol Cell 2005, 97:815-822.
2. Venneman N.G., van Erpecum K.J. Pathogenesis of gallstones. Gastroenterol Clin North Am 2010, 39:171-183.
3. Wang D.Q.H., Carey M.C. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic significance and identification of a stable liquid-crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996, 37:606-630.
4. van Erpecum K.J., Carey M.C. Influence of bile salts on molecular interactions between sphingomyelin and cholesterol: relevance to bile formation and stability. Biochim Biophys Acta 1997, 1345:269-282.
5. Hussaini S.H., Pereira S.P., Murphy G.M., Dowling R.H. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology 1995, 22:1735-1744.
6. Hay D.W., Calahane M.J., Timofeyeva N., Carey M.C. Molecular species of lecithins in human gallbladder bile. J Lipid Res 1993, 34:759-768.
7. Harvey P.R.C., Upadhya G.A., Strasberg S.M. Immunoglobulins as nucleating proteins in the gallbladder bile of patients with cholesterol gallstones. J Biol Chem 1991, 266:13996-14003.
8. Abei M., Schwarzendrube J., Nuutinen H., Broughan T.A., Kawczak P., Williams C., et al. Cholesterol crystallization-promoters in human bile: comparative potencies of immunoglobulins, α1-acid glycoprotein, phospholipase C, and aminopeptidase N. J Lipid Res 1993, 34:1141-1148.
9. Yamashita G., Ginanni Corradini S., Secknus R., Takabayashi A., Williams C., Hays L., et al. Biliary haptoglobin, a potent promoter of cholesterol crystallization at physiological concentrations. J Lipid Res 1995, 36:1325-1333.
10. Abei M., Nuutinen H., Kawczak P., Schwarzendrube J., Pillay S.P., Holzbach R.T. Identification of human biliary α1-acid glycoprotein as a cholesterol crystallization promotor. Gastroenterology 1994, 106:231-238.
11. Nuutinen H., Corradini S.G., Jüngst D., Lange V., Abei M., Schwarzendrube J., et al. Correlation between biliary α1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease. Dig Dis Sci 1995, 40:1174-1178.
12. Offner G.W., Gong D., Afdahl N.H. Identification of a 130-kilodalton human biliary concanavalin A binding protein as aminopeptidase N. Gastroenterology 1994, 106:755-762.
13. Lee S.M., LaMont J.T., Carey M.C. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. Studies in the prairie dog. J Clin Invest 1981, 67:1712-1723.
14. Kibe A., Holzbach R.T., LaRusso N.F., Mao S.J. Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile. Science 1984, 255:514-516.
15. Busch N., Lammert F., Matern S. Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins. Gastroenterology 1998, 115:129-138.
16. Miquel J.F., Nunez L., Amigo L., Gonzalez S., Raddatz A., Rigotti A., et al. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology 1998, 114:1016-1023.
17. van Erpecum K.J., Wang D.Q.-H., Lammert F., Paigen B., Groen A.K., Carey M.C. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: Soluble pronucleating proteins in gallbladder and hepatic biles. J Hepatol 2001, 35:444-451.
18. Amigo L., Quinones V., Leiva A., Busso D., Zanlungo S., Nervi F., et al. Apolipoprotein A-I deficiency does not affect biliary lipid secretion and gallstone formation in mice. Liver Int 2011, 31:263-271.
19. Corradini S.G., Elisei W., Giovannelli L., Ripani C., Della G.P., Corsi A., et al. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile. Gastroenterology 2000, 118:912-920.
20. Cong P., Pricolo V., Biancani P., Behar J. Effects of cholesterol on CCK-1 receptors and caveolin-3 proteins recycling in human gallbladder muscle. Am J Physiol Gastrointest Liver Physiol 2010, 299:G742-G750.
21. Xiao Z., Schmitz F., Pricolo V.E., Biancani P., Behar J. Role of caveolae in the pathogenesis of cholesterol-induced gallbladder muscle hypomotility. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1641-G1649.
22. van Erpecum K.J., Wang D.Q., Moschetta A., Ferri D., Svelto M., Portincasa P., et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 2006, 47:32-41.
23. Maurer K.J., Carey M.C., Fox J.G. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 2009, 136:425-440.
24. Maurer K.J., Ihrig M.M., Rogers A.B., Ng V., Bouchard G., Leonard M.R., et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005, 128:1023-1033.
25. Maurer K.J., Rao V.P., Ge Z., Rogers A.B., Oura T.J., Carey M.C., et al. T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 2007, 133:1304-1315.
26. Shimoyama T., Takahashi R., Abe D., Mizuki I., Endo T., Fukuda S. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010, 25(Suppl. 1):S86-S89.
27. Galman C., Miquel J.F., Perez R.M., Einarsson C., Stahle L., Marshall G., et al. Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. Gastroenterology 2004, 126:741-748.
28. Bergheim I., Harsch S., Mueller O., Schimmel S., Fritz P., Stange E.F. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J Lipid Res 2006, 47:42-50.
29. Renner O., Harsch S., Strohmeyer A., Schimmel S., Stange E.F. Reduced ileal expression of OSTalpha-OSTbeta in non-obese gallstone disease. J Lipid Res 2008, 49:2045-2054.
30. Renner O., Harsch S., Schaeffeler E., Winter S., Schwab M., Krawczyk M., et al. A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. PLoS One 2009, 4:e7321.
31. Kern Effects of dietary cholesterol on cholesterol and bile acids homeostasis in patients with cholesterol gallstones. J Clin Invest 1994, 93:1186-1194.
32. Jiang Z.Y., Jiang C.Y., Wang L., Wang J.C., Zhang S.D., Einarsson C., et al. Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. Biochem Biophys Res Commun 2009, 379:49-54.
33. Wang H.H., Portincasa P., Mendez-Sanchez N., Uribe M., Wang D.Q. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology 2008, 134:2101-2110.
34. Yu L., Hammer R.E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J.C., et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 2002, 99:16237-16242.
35. Buch S., Schafmayer C., Volzke H., Becker C., Franke A., von Eller-Eberstein H., et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39:995-999.
36. Grunhage F., Acalovschi M., Tirziu S., Walier M., Wienker T.F., Ciocan A., et al. Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol. Hepatology 2007, 46:793-801.
37. Katsika D., Magnusson P., Krawczyk M., Grunhage F., Lichtenstein P., Einarsson C., et al. Gallstone disease in Swedish twins: risk is associated with ABCG8 D19H genotype. J Intern Med 2010, 268:279-285.
38. Biddinger S.B., Haas J.T., Yu B.B., Bezy O., Jing E., Zhang W., et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med 2008, 14:778-782.
39. van Mil S.W., van der Woerd W.L., van der B.G., Sturm E., Jansen P.L., Bull L.N., et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127:379-384.
40. Poupon R., Arrive L., Rosmorduc O. The cholangiographic features of severe forms of ABCB4/MDR3 deficiency-associated cholangiopathy in adults. Gastroenterol Clin Biol 2010, 34:380-387.
41. Rosmorduc O., Hermelin B., Boelle P.Y., Parc R., Taboury J., Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003, 125:452-459.
42. Acalovschi M., Tirziu S., Chiorean E., Krawczyk M., Grunhage F., Lammert F. Common variants of ABCB4 and ABCB11 and plasma lipid levels: a study in sib pairs with gallstones, and controls. Lipids 2009, 44:521-526.
43. Bronsky J., Jirsa M., Nevoral J., Hrebicek M. Role of common canalicular transporter gene variations in aetiology of idiopathic gallstones in childhood. Folia Biol (Praha) 2010, 56:9-13.
44. Moschetta A., Bookout A.L., Mangelsdorf D.J. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 2004, 10:1352-1358.
45. Kovacs P., Kress R., Rocha J., Kurtz U., Miquel J.F., Nervi F., et al. Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans. J Hepatol 2008, 48:116-124.
46. Gadaleta R.M., van Mil S.W., Oldenburg B., Siersema P.D., Klomp L.W., van Erpecum K.J. Bile acids and their nuclear receptor FXR: relevance for hepatobiliary and gastrointestinal disease. Biochim Biophys Acta 2010, 1801:683-692.
47. Uppal H., Zhai Y., Gangopadhyay A., Khadem S., Ren S., Moser J.A., et al. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization. Hepatology 2008, 47:1331-1342.
48. Jiang Z.Y., Parini P., Eggertsen G., Davis M.A., Hu H., Suo G.J., et al. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res 2008, 49:464-472.
49. Lambou-Gianoukos S., Heller S.J. Lithogenesis and bile metabolism. Surg Clin North Am 2008, 88:1175-1194. [vii].
50. Haverfield E.V., McKenzie C.A., Forrester T., Bouzekri N., Harding R., Serjeant G., et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood 2005, 105:968-972.
51. Freudenberg F., Broderick A.L., Yu B.B., Leonard M.R., Glickman J.N., Carey M.C. Pathophysiological basis of liver disease in cystic fibrosis employing a DeltaF508 mouse model. Am J Physiol Gastrointest Liver Physiol 2008, 294:G1411-G1420.
52. Brink M.A., Mendez-Sanchez N., Carey M.C. Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology 1996, 110:1945-1957.
53. Mendez-Sanchez N., Brink M.A., Paigen B., Carey M.C. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents. Gastroenterology 1998, 115:722-732.
54. Brink M.A., Slors J.F., Keulemans Y.C., Mok K.S., De Waart D.R., Carey M.C., et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999, 116:1420-1427.
55. Wasmuth H.E., Keppeler H., Herrmann U., Schirin-Sokhan R., Barker M., Lammert F. Coinheritance of Gilbert syndrome-associated UGT1A1 mutation increases gallstone risk in cystic fibrosis. Hepatology 2006, 43:738-741.
56. Buch S., Schafmayer C., Volzke H., Seeger M., Miquel J.F., Sookoian S.C., et al. Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition. Gastroenterology 2010, 139:1942-1951.